verapamil and fingolimod hydrochloride

verapamil has been researched along with fingolimod hydrochloride in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Campos, CR; Cannon, RE; Hawkins, BT; Miller, DS; Peart, JC	1

Other Studies

1 other study(ies) available for verapamil and fingolimod hydrochloride

Article	Year
Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain. Proceedings of the National Academy of Sciences of the United States of America, 2012, Sep-25, Volume: 109, Issue:39 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport, Active; Blood-Brain Barrier; Calcium Channel Blockers; Capillaries; Drug Delivery Systems; Female; Fingolimod Hydrochloride; Immunosuppressive Agents; Lysophospholipids; Nerve Tissue Proteins; Organophosphates; Propylene Glycols; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; Signal Transduction; Sphingolipids; Sphingosine; Tight Junctions; Tumor Necrosis Factor-alpha; Verapamil	2012

Article

Year

Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain.

Proceedings of the National Academy of Sciences of the United States of America, 2012, Sep-25, Volume: 109, Issue:39

Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport, Active; Blood-Brain Barrier; Calcium Channel Blockers; Capillaries; Drug Delivery Systems; Female; Fingolimod Hydrochloride; Immunosuppressive Agents; Lysophospholipids; Nerve Tissue Proteins; Organophosphates; Propylene Glycols; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; Signal Transduction; Sphingolipids; Sphingosine; Tight Junctions; Tumor Necrosis Factor-alpha; Verapamil

2012